Navigation Links
Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC
Date:9/9/2011

SAN DIEGO, Sept. 9, 2011 /PRNewswire/ -- Optimer Pharmaceuticals (NASDAQ: OPTR) today announced that 11 abstracts reporting new research findings for DIFICID™ (fidaxomicin) tablets will be presented at the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking place September 17-20 in Chicago. DIFICID was approved by the U.S. Food and Drug Administration (FDA) in May of 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older.  CDAD is a significant medical problem in hospitals and long-term care facilities, and DIFICID is the first antibacterial drug approved for the treatment of CDAD in 25 years.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

The 11 new data presentations provide additional insight on the safety and efficacy of DIFICID and further advance the medical community's understanding of the potential role of DIFICID in treating CDAD.

In addition, Sherwood Gorbach, MD, Chief Scientific Officer at Optimer, will present a session titled "The Role of Narrow-Spectrum Agents and Novel Mechanisms of Action in Containing Antibiotic Resistance" during an ICAAC-sponsored symposium on Sunday, September 18 from 12:15 PM to 12:45 PM Central Time in room W179b.

"Our presence at ICAAC reinforces Optimer's leadership in advancing C. difficile related research and medicine," said Glenn Tillotson, Ph.D., Senior Vice President, Medical Affairs for Optimer. "We remain committed to engaging in research that will improve how the medical community treats patients with CDAD."  

Optimer Pharmaceuticals representatives will provide information about DIFICID and its role in the treatment of CDAD during ICAAC at booth #909. All presentations about research
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
2. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
4. Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
5. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
6. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
8. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
9. Optimer Pharmaceuticals Expands Senior Management Team
10. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
11. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SAN FRANCISCO , July 2, 2015  The ... www.tryloud.com ), the world,s first HIPAA compliant mobile app ... delivery of farm-to-table fresh medical marijuana, announced today that ... Unlike Eaze, Meadow and more than half ... in the last year, Loud Cannabis is unique in ...
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
(Date:7/2/2015)... , July 2, 2015  The Commission ... agreement with ASHP, an organization that represents pharmacists ... a provider of continuing education for recertification of ... track of geriatric programs for this purpose.  ASHP ... as authorized providers for the CCGP Professional Development ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... DUBLIN, Calif., June 16 SuperGen Inc.,(Nasdaq: ... to the discovery, rapid,development and commercialization of ... announced at the 13th Congress of the,European ... its JAK2 kinase inhibitor, prevents tumor cell ...
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
Cached Medicine Technology:SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking ... the University of Minnesota, they knew it would save the university energy and ... award-winning choice: the total energy savings after installation was an impressive 89 percent, ...
(Date:7/2/2015)... ... 2015 , ... With summer in full swing, Americans are flocking to Canada’s many lakes to ... for fishing in the world, and it’s easy to understand why. From the Pacific Northwest ... , Recreational fishing is a huge industry, and Americans make up the vast majority ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... most versatile smart light bulbs on the market. , According to the U.S. Department ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Six months ahead ... solo cross-country walk to raise awareness and money for the Pulmonary Hypertension Association ... arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday ...
Breaking Medicine News(10 mins):Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... to have developed a device to facilitate keyhole surgery for ... as a breakthrough in spinal treatment. // ... neurosurgery at King George's Medical University (KGMU), has developed a ... the complicated and painful procedures practised so far. ...
... XR drug for attention deficit hyperactivity disorder (ADHD) needs to ... the US FDA regulators. // ,It has ... about the side effects of the drug such as hallucinations ... with no identifiable risk factors. The FDA had prepared a ...
... was caught in the throes of a bizarre incident that threw ... whole of the ICU was held hostage by a patient’s relative. ... that his child, who was on the road to recovery, not ... ,The police was informed, but they did not react immediately. ...
... hand, foot and mouth disease (HFMD). Eight children have already ... situation the state government has worked out a series of preventive ... in five areas of the state, bringing the total number to ... to spread to the interior rural areas. Cases are seen at ...
... teenager to death. Disturbing images of this violent act were captured// ... truth, saying it was a natural death, but upon a second ... of 14, had been brutally beaten to death. This incident and ... demand in the U.S to close down all the boot camps. ...
... of AGD Impact, the newsmagazine of the Academy of ... way to correct crooked teeth. Orthodontics, the branch of ... help in improving the "stability, function, and health of ... feel better about themselves,” said AGD spokesperson James G. ...
Cached Medicine News:Health News:New Device Developed For Treating Cervical Spondylitis 2Health News:Malaysia to Beef in Medical Care to Fight against HFMD 2
Used for emergency airway access when conventional endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
... Standard/Conventional Blade. Stainless Steel. Lamp supplied ... tradition of high quality standard incandescent ... blades have been continually refined through ... over to minimize maintenance requirements. They ...
... Rusch Snap-Light™ laryngoscope blades are designed ... diameter fiber optic bundle can be removed ... hard to reach areas. Our unique snap-on ... The bright focused blades are interchangeable with ...
... Greenspec Laryngoscopes are a high quality ... of bringing greater standardization to fiberoptic laryngoscopes. ... fiberoptic and indicates it's ability to interconnect ... Fiberoptic light offers a cool, bright and ...
Medicine Products: